Woman and Man
- | Country :
- United States
- Germany
- Finland
- The 10 others...
- | organs : -
- | Specialty : -
Extract
This is a randomized, placebo-controlled, double-blind, multicenter phase III/IV study to compare the efficacy and safety of Zemaira® with placebo in subjects with emphysema due to alpha1-proteinase inhibitor deficiency. The effect of Zemaira® on the progression of emphysema will be assessed by the decline of lung density, measured by computed tomography (CT).
Inclusion criteria
- Alpha1-proteinase Inhibitor Deficiency ,Emphysema